4-Amino-1-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]-1,2-dihydropyrimidin-2-one

Catalog No. :
ACPVLS916
CAS No. :
338420-22-7
Molecular Formula :
C10H6ClF3N4O
Molecular Weight :
290.63

IUPAC Name:4-amino-1-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)pyrimidin-2(1H)-one

4-Amino-1-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]-1,2-dihydropyrimidin-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$324.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Amino-1-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]-1,2-dihydropyrimidin-2-one
IUPAC Name4-amino-1-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)pyrimidin-2(1H)-one
MDL No.MFCD00172049
Molecular FormulaC10H6ClF3N4O
Molecular Weight290.63
SMILESO=C1N=C(N)C=CN1C2=NC=C(C(F)(F)F)C=C2Cl
InChI KeyYUVWQGAGIKXRRG-UHFFFAOYSA-N
Synonym4-amino-1-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]-1,2-dihydropyrimidin-2-one;4-AMINO-1-[3-CHLORO-5-(TRIFLUOROMETHYL)-2-PYRIDINYL]-2(1H)-PYRIMIDINONE;2(1H)-Pyrimidinone, 4-amino-1-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]-
CAS No.338420-22-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACPVLS916 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  4. Then
  5. ACPVLS916 route product structure diagram
    ACPVLS916338420-22-7
Inquiry

2. ACPVLS916 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPVLS916 route product structure diagram
    ACPVLS916338420-22-7
Inquiry

Comments (0)